| Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint … DF Hanley, RE Thompson, M Rosenblum, G Yenokyan, K Lane, N McBee, ... The Lancet 393 (10175), 1021-1032, 2019 | 814 | 2019 |
| Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial DF Hanley, K Lane, N McBee, W Ziai, S Tuhrim, KR Lees, J Dawson, ... The Lancet 389 (10069), 603-611, 2017 | 469 | 2017 |
| Minimally invasive surgery plus recombinant tissue-type plasminogen activator for intracerebral hemorrhage evacuation decreases perihematomal edema WA Mould, JR Carhuapoma, J Muschelli, K Lane, TC Morgan, NA McBee, ... Stroke 44 (3), 627-634, 2013 | 417 | 2013 |
| Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial DF Hanley, RE Thompson, J Muschelli, M Rosenblum, N McBee, K Lane, ... The Lancet Neurology 15 (12), 1228-1237, 2016 | 392 | 2016 |
| Accuracy of the ABC/2 score for intracerebral hemorrhage: systematic review and analysis of MISTIE, CLEAR-IVH, and CLEAR III AJS Webb, NL Ullman, TC Morgan, J Muschelli, J Kornbluth, IA Awad, ... Stroke 46 (9), 2470-2476, 2015 | 176 | 2015 |
| Surgical performance determines functional outcome benefit in the minimally invasive surgery plus recombinant tissue plasminogen activator for intracerebral hemorrhage … IA Awad, SP Polster, J Carrión-Penagos, RE Thompson, Y Cao, A Stadnik, ... Neurosurgery 84 (6), 1157-1168, 2019 | 137 | 2019 |
| Resolution of intraventricular hemorrhage varies by ventricular region and dose of intraventricular thrombolytic: the Clot Lysis: Evaluating Accelerated Resolution of IVH … AJS Webb, NL Ullman, S Mann, J Muschelli, IA Awad, DF Hanley Stroke 43 (6), 1666-1668, 2012 | 101 | 2012 |
| Validated automatic brain extraction of head CT images J Muschelli, NL Ullman, WA Mould, P Vespa, DF Hanley, CM Crainiceanu Neuroimage 114, 379-385, 2015 | 99 | 2015 |
| One-year outcome trajectories and factors associated with functional recovery among survivors of intracerebral and intraventricular hemorrhage with initial severe disability VA Shah, RE Thompson, G Yenokyan, JN Acosta, R Avadhani, R Dlugash, ... JAMA neurology 79 (9), 856-868, 2022 | 90 | 2022 |
| PItcHPERFeCT: primary intracranial hemorrhage probability estimation using random forests on CT J Muschelli, EM Sweeney, NL Ullman, P Vespa, DF Hanley, ... NeuroImage: Clinical 14, 379-390, 2017 | 83 | 2017 |
| Intracranial hypertension and cerebral perfusion pressure insults in adult hypertensive intraventricular hemorrhage: occurrence and associations with outcome WC Ziai, CB Thompson, S Mayo, N McBee, WD Freeman, R Dlugash, ... Critical care medicine 47 (8), 1125-1134, 2019 | 66 | 2019 |
| Determinants of external ventricular drain placement and associated outcomes in patients with spontaneous intraventricular hemorrhage DB Herrick, N Ullman, S Nekoovaght-Tak, DF Hanley, I Awad, S LeDroux, ... Neurocritical care 21, 426-434, 2014 | 57 | 2014 |
| Characterization of intraventricular and intracerebral hematomas in non-contrast CT WL Nowinski, RS Gomolka, G Qian, V Gupta, NL Ullman, DF Hanley The neuroradiology journal 27 (3), 299-315, 2014 | 27 | 2014 |
| No exacerbation of perihematomal edema with intraventricular tissue plasminogen activator in patients with spontaneous intraventricular hemorrhage W Ziai, T Moullaali, S Nekoovaght-Tak, N Ullman, JS Brooks, TC Morgan, ... Neurocritical care 18, 354-361, 2013 | 27 | 2013 |
| MISTIE Investigators: minimally invasive surgery plus recombinant tissue-type plasminogen activator for intracerebral hemorrhage evacuation decreases perihematomal edema WA Mould, JR Carhuapoma, J Muschelli, K Lane, TC Morgan, NA McBee, ... Stroke 44 (3), 627-634, 2013 | 18 | 2013 |
| Relationship of white matter lesions with intracerebral hemorrhage expansion and functional outcome: MISTIE II and CLEAR III BM Hansen, N Ullman, J Muschelli, B Norrving, R Dlugash, R Avadhani, ... Neurocritical care 33, 516-524, 2020 | 16 | 2020 |
| De novo HECW2 mutation associated with epilepsy, developmental decline, and intellectual disability: case report and review of literature NL Ullman, CL Smith-Hicks, S Desai, CE Stafstrom Pediatric neurology 85, 76-78, 2018 | 16 | 2018 |
| CLEAR III Investigators. Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo … DF Hanley, K Lane, N McBee, W Ziai, S Tuhrim, KR Lees, J Dawson, ... Lancet 389 (10069), 603-611, 2017 | 15 | 2017 |
| Applicability of clinical trials in an unselected cohort of patients with intracerebral hemorrhage BM Hansen, N Ullman, B Norrving, DF Hanley, A Lindgren Stroke 47 (10), 2634-2637, 2016 | 15 | 2016 |
| Early therapy intensity level (TIL) predicts mortality in spontaneous intracerebral hemorrhage WC Ziai, AA Siddiqui, N Ullman, DB Herrick, G Yenokyan, N McBee, ... Neurocritical care 23, 188-197, 2015 | 15 | 2015 |
John MuschelliAssociate Scientist, Johns Hopkins School of Public HealthEmail yang diverifikasi di jhsph.edu